The Food and Drug Administration has given another possible COVID-19 vaccine fast track designation.
The vaccine, produced by Novavax, will begin phase 3 clinical trials by the end of November.
Story: https://wfts.tv/3pc9p8u
FDA Grants Fast Track For Novavax COVID-19 Vaccine
It's coronavirus vaccine candidate, NVX-CoV2373, is in the late-phase of clinical development using a Novavax’ nanoparticle..
WJZ Baltimore
